RINDI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 4.080
AS - Asia 3.496
EU - Europa 2.303
SA - Sud America 431
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 10.476
Nazione #
US - Stati Uniti d'America 3.953
SG - Singapore 1.414
CN - Cina 929
VN - Vietnam 579
UA - Ucraina 468
IE - Irlanda 447
SE - Svezia 354
BR - Brasile 336
FI - Finlandia 319
HK - Hong Kong 261
DE - Germania 250
ZA - Sudafrica 126
NL - Olanda 105
FR - Francia 97
CA - Canada 89
GB - Regno Unito 86
IN - India 64
IT - Italia 63
TR - Turchia 60
AR - Argentina 44
BD - Bangladesh 34
RU - Federazione Russa 29
IQ - Iraq 21
MX - Messico 21
BE - Belgio 18
JP - Giappone 16
CZ - Repubblica Ceca 14
PH - Filippine 13
TH - Thailandia 13
ES - Italia 12
PK - Pakistan 12
VE - Venezuela 12
EC - Ecuador 10
CO - Colombia 9
MA - Marocco 9
CL - Cile 8
ID - Indonesia 8
JO - Giordania 8
PL - Polonia 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
EU - Europa 7
KE - Kenya 7
KR - Corea 7
SA - Arabia Saudita 7
IL - Israele 6
JM - Giamaica 5
PE - Perù 5
BG - Bulgaria 4
EG - Egitto 4
KZ - Kazakistan 4
MY - Malesia 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
DO - Repubblica Dominicana 2
GR - Grecia 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
IR - Iran 1
KH - Cambogia 1
LU - Lussemburgo 1
MN - Mongolia 1
MR - Mauritania 1
NO - Norvegia 1
NP - Nepal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.476
Città #
Singapore 615
Chandler 464
Jacksonville 451
Dublin 446
San Jose 369
Ashburn 361
Santa Clara 340
Beijing 259
Hong Kong 251
Dearborn 244
Ho Chi Minh City 188
Boardman 163
Hanoi 131
Nanjing 121
Johannesburg 120
Princeton 100
San Mateo 97
Los Angeles 85
Dallas 82
Lauterbourg 81
Ann Arbor 78
Toronto 70
Wilmington 62
Izmir 50
Helsinki 48
New York 38
Shanghai 33
Nanchang 32
Da Nang 31
Munich 31
Hebei 30
Pune 30
Buffalo 29
Kunming 28
Shenyang 28
Jinan 26
São Paulo 23
Haiphong 22
Hefei 20
Woodbridge 20
Tianjin 19
Brussels 18
Changsha 15
Guangzhou 15
Moscow 15
Can Tho 13
Norwalk 12
Hangzhou 11
Hải Dương 11
Jiaxing 11
London 11
Belo Horizonte 10
Chennai 10
Columbus 10
Tokyo 10
Zhengzhou 10
Biên Hòa 9
Rio de Janeiro 9
Stockholm 9
Turku 9
Borås 8
Des Moines 8
Parma 8
Tashkent 8
Amman 7
Auburn Hills 7
Baku 7
Bremen 7
Brno 7
Brooklyn 7
Fremont 7
Nairobi 7
Ottawa 7
Redondo Beach 7
Campinas 6
Nuremberg 6
Prague 6
San Francisco 6
Seattle 6
Taiyuan 6
Warsaw 6
Atlanta 5
Baghdad 5
Chicago 5
Elk Grove Village 5
Frankfurt am Main 5
Haikou 5
Hưng Yên 5
Jeddah 5
Newark 5
Ninh Bình 5
Quảng Ngãi 5
Rockville 5
Thái Nguyên 5
Bauru 4
Bologna 4
Brasília 4
Buenos Aires 4
Caracas 4
Casablanca 4
Totale 6.167
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 194
A high resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications 160
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 159
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 159
Endocrine tumors of the gastrointestinal system 158
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 155
A randomised, double-blind, trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over five years 146
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 145
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 144
Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations 141
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor deficient mice. 140
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors 136
Criteria for malignancy in gastrointestinal endocrine tumors 134
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 134
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. 133
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non small cell lung cancer(NSCLC) and fine needle aspirates from distant metastatic sites. 131
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 131
Characterisation of gastric ghrelin cells in man and other mammals – Studies in adult and foetal tissues 130
CONSENSUS GUIDELINES ON THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS: WHY SUCH GUIDELINES AND HOW WE WENT ABOUT IT. 130
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 126
Consensus guidelines for the management of patients with digestive neuroendocrine tumors -4- well-differentiated pancreatic tumor/carcinoma: insulinoma. 125
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS -2- WELL-DIFFERENTIATED DUODENAL TUMOR/CARCINOMA (EXCLUDING GASTRINOMAS). 124
Classification of the neuroendocrine phenotype in cancer 124
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 123
Unusual case of giant typical carcinoid tumor 123
Classification of neuroendocrine tumours. 121
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 121
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE ENDOCRINE TUMORS -1- WELL-DIFFERENTIATED GASTRIC TUMORS/CARCINOMAS. 120
Three different synchronous unilateral lung cancers: a case report 120
Etiology, molecular pathogenesis and genetics 119
Autoimmune gastritis 119
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract 119
Anatomia patologica e tumori rari 116
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. 111
Central Ghrelin gastroprotection involves nitric oxide/prostaglandins cross-talk. 111
Linee guida e criteri diagnostici minimi per la diagnosi istologica dei tumori endocrini del tratto gastroenteropancreatico 109
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases 105
Optimisation of isolation of richly pure and homogenous primary human colonic smooth muscle cells 104
Highlights on biology of endocrine tumours of the gut and pancreas 104
Ghrelin expression and actions. A novel peptide for an old cell type of the diffuse endocrine system 103
Ghrelin in gastroenteric pathophysiology 100
Prognostic value of Goseki histological classification of adenocarcinoma of the cardia 100
Solitary microcarcinoid of the rectal stump in ulcerative colitis. Case report 99
Prognostic relevance of a novel TNM-classification system for gastroenteropancreatic neuroendocrine tumors of foregut origin 99
Primary mixed adenocarcinoma and small cell carcinoma of the appendix. A clinicopathologic, immunohistochemical and molecular study of a hitherto unreported tumor 98
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinico-pathologic study. 98
Unusual prostatic carcinoma with endocrine basophilic FSH-immunoreactive cells 97
A Refractory pleural small cell carcinoma in never smoker. A case report. 97
GI Tract, General Pathology of Endocrine Growths 95
Peptide YY expression is an early event in intestinal endocrine cell differentiation: evidence from normal and transgenic mice. 95
Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. 95
Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma 95
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice 93
Il pancreas endocrino. 93
The ontogeny and tissue specific regulation of ghrelin mRNA expression in the rat strongly indicate that ghrelin is primarily involved in the control of extraendocrine functions 92
Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells 92
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa 92
Introduction to a revised clinicopathological classification of the neuroendocrine tumors of the gastroenteropancreatic tract 91
The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. 91
Development of neuroendocrine tumors in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. 91
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system 90
Mismatch repair system (MMR) status correlates with response and survival in non small cell lung cancer (NSCLC) patients. 90
The phenotype of gut endocrine tumors 90
PYY-Tag transgenic mice displaying abnormal (H(+)-K(+)ATPase activity and gastric mucosal barrier impairment 89
Molecular aspects of the endocrine tumors of the pancreas and the gastrointestinal tract 89
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 88
Gastroenteropancreatic neuroendocrine tumours. 87
Effects of long-term esomeprazole treatment on the gastric mucosa 87
Gastrinomas 86
Pathobiology and classification of digestive endocrine tumors 86
Vesicular monoamine transporter 2 as a marker of gastric ECL cell tumors 86
Origin and genetic background of insulinoma 86
Gastric neuroendocrine tumors - carcinoid and poorly differentiated carcinoma 86
Epidemiology of carcinoid neoplasm in Vaud, Switzerland, 1974-1997 86
Insulinoma 86
Prognostic factors in gastrointestinal endocrine tumors 86
Gastric endocrine cells: types function and growth 86
Transient developmental expression of secretin in serotoninergic neurons of mouse brain 85
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. 85
The endocrine pancreas 84
Effect of CCK-B gastrin receptor blockade on chemically-induced colon carcinogenesis in mice: follow-up at 52 weeks 84
TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. 84
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. 83
Évaluation de la malignité dans les tumeurs endocrines digestives: recommandations pratiques. 83
Dilated intercellular spaces as marker of reflux disease: histology, semiquantitative score and morphometry at light microscopy 82
Is TCRg clonality assay useful to detect early celiac disease? 82
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. 81
Neuroendocrine tumors: history and histopathology 81
The normal endocrine cell of the gut. Changing concepts and new evidences 80
Histogenesis, diagnosis and molecular basis of the endocrine tumors of the digestive tract and pancreas 80
Ghrelin expression in gut endocrine tumours 79
Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active ß-catenin. 79
Pathology and biology of gastric neuroendocrine tumors in man 78
Endocrine tumours of the gut and pancreas tumor biology and classification 77
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 77
Morphological, molecular, and prognostic aspects of gastric endocrine tumors 70
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. 70
Dilated intercellular spaces: a major morphological feature of esophagitis. 64
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells 63
Pancreatic endocrine tumors 62
Totale 10.387
Categoria #
all - tutte 33.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 110 6
2021/2022455 4 1 0 28 17 6 67 97 18 36 63 118
2022/20231.595 197 156 62 129 155 173 15 101 551 10 38 8
2023/2024458 20 71 9 15 41 141 12 16 6 14 38 75
2024/20251.934 19 115 143 60 262 319 32 51 249 217 122 345
2025/20263.400 266 364 329 323 575 252 388 77 553 241 32 0
Totale 10.488